Similar Papers

Paper Title
Journal
Date
Author
Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial
...
The Lancet Respiratory Medicine | VOL. 8
, et. al. ...
25 Feb 2020
Correlation of Cough With Disease Activity and Treatment With Cyclophosphamide in Scleroderma Interstitial Lung Disease: Findings From the Scleroderma Lung Study
Arthur C Theodore ... Donald P Tashkin
Chest | VOL. 142
Arthur C Theodore, et. al.Arthur C Theodore ... Donald P Tashkin
01 Sep 2012
Speech and language therapy for management of chronic cough.
Claire Slinger ... Jessica Matthews
Cochrane Database of Systematic Reviews | VOL. 7
Claire Slinger, et. al.Claire Slinger ... Jessica Matthews
23 Jul 2019
Efficacy and Tolerability of Gefapixant for Treatment of Refractory or Unexplained Chronic Cough
Elena Kum ... Imran Satia
JAMA | VOL. 330
Elena Kum, et. al.Elena Kum ... Imran Satia
11 Sep 2023
View more papers

More From: Thorax

Paper Title
Journal
Date
Author
Pulmonary rehabilitation: one size does not fit all
Narelle S Cox ... Anne E Holland
Thorax | VOL. -
Narelle S Cox, et. al.Narelle S Cox ... Anne E Holland
03 Feb 2025
Extracellular vesicles offer enticing opportunities to target and treat lung inflammation
Sally Yunsun Kim
Thorax | VOL. -
Sally Yunsun KimSally Yunsun Kim
03 Feb 2025
Availability, cost and affordability of essential medicines for smoking cessation in low-income and middle-income countries: a cross-sectional study
Catherine Plum ... David Halpin
Thorax | VOL. -
Catherine Plum, et. al.Catherine Plum ... David Halpin
03 Feb 2025
Role of inflammasomes in acute respiratory distress syndrome
Luke Flower ... Charlotte Summers
Thorax | VOL. -
Luke Flower, et. al.Luke Flower ... Charlotte Summers
30 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.